Stocks to Keep Your Eyes on: Celestica, Inc. (NYSE:CLS) , Nu Skin Enterprises, Inc. (NYSE:NUS)

On 4/19/2017, Shares of Celestica, Inc. (NYSE:CLS) closed at $14.32 in last trading day. After noting the initial trading entry at $14.30, it reached to a day’s high of $14.44 and moved to a day’s low of $14.19. The recent daily volume was 472.73 thousand as contrast to it’s an average volume of 430.99 thousand.

Technical Indicators:

The last close of the Celestica, Inc. stock reflects that it traded up +1.98% from its 50-day moving average of $14.04. The stock traded above +12.78% to its 200-day MA of $12.70. Furthermore, it moved lower -2.85% from its 52-week high of $14.74 and +62.17% up from $8.83, which is 52-week low of the stock.

During the last month, Celestica Inc.’s (CLS) has changed 3.69% and performed 37.03% over the last 6 months. The mean rating score for this stock is at 2.50. This rating scale contains from 1 to 5 with 5 representing a Strong Sell, 1 signifying a Strong Buy and 3 demonstrating a Hold. The Volatility was noted at 2.23% in recent month and observed Weekly Volatility of 2.21%.

Celestica Inc. provides supply chain solutions in Canada and internationally. The company offers a range of services, including design and development, engineering, supply chain management, new product introduction, component sourcing, electronics manufacturing, assembly and test, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, and after-market repair and return services. Its products and services are used in various applications, such as servers, networking and telecommunications equipment, storage systems, optical equipment, aerospace and defense electronics, healthcare products and applications, semiconductor equipment, and industrial and alternative energy products. The company serves customers in the communications, consumer, aerospace and defense, industrial, healthcare, smart energy, semiconductor equipment, servers, and storage end markets. Celestica Inc. was incorporated in 1996 and is headquartered in Toronto, Canada.

Nu Skin Enterprises, Inc. (NYSE:NUS) finalized the last transaction at value of $55.00, with a daily change of -0.42% or -0.23 points. The company maintained volume of 444.67 thousand shares. In past trading day, the stock hit the maximum price of $55.46 and touched to minimum value of $55.00. It has a market cap of $ 2.89B.

Technical Indicators:

As of last trade close, the stock is trading  downside -16.72% from its one year high of $66.04 and moved +48.29% upward from $37.09, which is one year low of the stock.

The stock traded above +3.94% from its 50-day moving average of $52.91. Furthermore, the stock moved up +2.19% to its 200-day MA of $ 53.82.

Nu Skin Enterprises, Inc.’s (NUS) moved with shift of 2.17% in the past week. Over the last three months, the shares of the company have changed 7.39% and performed -12.77% over the last six months. The stock currently has Monthly Volatility of 1.93% and Weekly Volatility of 1.30%.

Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC Transformation anti-aging skin care systems; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of aging, such as the influence of certain ingredients on gene expression. The company sells its products directly as well as through distributors, and its retail stores and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.


Leave a Reply

Your email address will not be published. Required fields are marked *